Japanese microbiome therapeutics biotech developing drug-discovery programs and medical services based on gut microbiome research and clinical evidence
Japanese microbiome therapeutics biotech developing drug-discovery programs and medical services based on gut microbiome research and clinical evidence. Its work includes fecal microbiota transplantation (FMT), microbiome-based treatments such as a program for ulcerative colitis, and platforms for recruiting and supporting stool donors.